SCHEMBL1637154

SCHEMBL1637154

CCCCCNC(=O)c1cnc(N)s1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.50
NAAA Q02083 3/20 0.47
ALOX15 P16050 3/20 0.46
RAB9A P51151 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.44
DRD2 P14416 1/20 0.44
HRH2 P25021 1/20 0.44
HRH1 P35367 1/20 0.44
DRD3 P35462 1/20 0.44
HRH4 Q9H3N8 1/20 0.44
HRH3 Q9Y5N1 1/20 0.44
CSNK2A2 P19784 1/20 0.44
KDR P35968 1/20 0.44
CSNK2B P67870 1/20 0.44
CSNK2A1 P68400 1/20 0.44
GAA P10253 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
RXFP1 Q9HBX9 1/20 0.43
CA2 P00918 1/20 0.43
MAOB P27338 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12801181 0.89 POLB (0.43) KDM4ERAB9AGAAESR1
SCHEMBL11652618 0.84 KDM4E (0.52) KDM4ENAAARAB9AL3MBTL1CSNK2A2
SCHEMBL11652714 0.84 KDM4E (0.52) KDM4ENAAARAB9AL3MBTL1CSNK2A2
SCHEMBL11652486 0.84 KDM4E (0.52) KDM4ENAAARAB9AL3MBTL1CSNK2A2
SCHEMBL11652981 0.84 KDM4E (0.52) KDM4ENAAARAB9AL3MBTL1CSNK2A2
SCHEMBL11653068 0.84 KDM4E (0.52) KDM4ENAAARAB9AL3MBTL1CSNK2A2
SCHEMBL2990440 0.82 KDM4E (0.47) KDM4EALOX15RAB9AL3MBTL1NPSR1
SCHEMBL12800947 0.82 HDAC4 (0.45) HDAC4HDAC1HDAC6
SCHEMBL11749921 0.79 KDM4E (0.48) KDM4ENAAARAB9AL3MBTL1CSNK2A2
SCHEMBL11753542 0.79 KDM4E (0.48) KDM4ENAAARAB9AL3MBTL1CSNK2A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7932386-B2 Preparation of 2-amino-thiazole-5-carboxylic-acid derivatives BRISTOL-MYERS SQUIBB COMPANY (US) 2011-04-26 US disclosed
US-20090030203-A1 PREPARATION OF 2-AMINO-THIAZOLE-5-CARBOXYLIC-ACID DERIVATIVES BRISTOL-MYERS SQUIBB COMPANY (US) 2009-01-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090030203-A1 PREPARATION OF 2-AMINO-THIAZOLE-5-CARBOXYLIC-ACID DERIVATIVES H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, ABAT, AADAT KDM4E 3987/4885NAAA 100/4885ALOX15 3546/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.